Skip to main content
Top

13-11-2019 | Axial spondyloarthritis | Video | Article

Expert commentary: The COAST-X trial

print
PRINT
insite
SEARCH

Laura Coates talks about the COAST-X trial results, and explores how ixekizumab may fit into the treatment paradigm for nonradiographic axial spondyloarthritis (5:12).

Transcript

Back to the ACR/ARP 2019 conference hub

print
PRINT